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We report the first documented cases of sandfly fever 
virus infection in travellers returning from Malta to 
Switzerland in autumn 2011. These cases illustrate the 
importance of considering sandfly-borne viral infec-
tion in the differential diagnosis of febrile patients 
from the Mediterranean island Malta. Raising aware-
ness among physicians is relevant especially now at 
the beginning of the summer tourist season.
On 17 October 2011, a Swiss citizen was hospitalised 
with fever, nausea, vomiting and intensifying head-
ache two days after his return from the Mediterranean 
island Malta, where he had spent two weeks on Gozo 
Island. Nine days before his admission, the patient had 
suffered from back pain, tiredness and subfebrile tem-
peratures, but had recovered after medication with the 
non-steroid inflammatory drug ibuprofen. The patient’s 
wife had suffered from similar, less intense symptoms. 
Both had multiple insect bites and were diagnosed with 
laboratory-confirmed sandfly fever. The couple’s two 
accompanying children and two further travel compan-
ions had been frequently bitten by small flying insects, 
but suffered no symptoms. 
Case 1
Case 1, a man in his late 40s, was admitted to hospi-
tal in Switzerland two days after his return from Malta 
and presented in a reduced general condition. He had 
fever (38.4 °C), a generalised rash and complained of 
severe headache, without meningism. Multiple skin 
lesions due to insect bites were visible on the extremi-
ties (Figure). 
Laboratory tests for this patient, including C-reactive 
protein, electrolytes and transaminases revealed no 
abnormalities, and a complete blood cell count showed 
relative lymphopenia (17.9%, normal range: 20–52%). 
Because of the recent stay in a Mediterranean coun-
try and the multiple skin lesions, a sandfly fever 
virus (SFV) infection (pappataci fever) was assumed. 
Serology for SFV was positive on a serum sample taken 
on the day after admission, i.e. 10 days after onset of 
first symptoms on Malta. An immunoblot (IB) for bun-
yaviruses (Mikrogen, Munich, Germany) showed reac-
tivity with the TOSV bands, with stronger intensity than 
the cut-off reference, indicating the presence of IgM 
and IgG antibodies against TOSV. An indirect immuno-
fluorescence test (IIFT) (Sandfly fever virus Mosaic 1, 
Sandfly fever virus serotypes Sicilian, Naples, Toscana, 
Cyprus; Euroimmun, Lübeck, Germany) revealed high 
serum antibody titres against Toscana and Naples 
SFV (Table), indicating an infection with a phlebovirus 
belonging to the SFNV serological complex. 
In a convalescent serum, taken 52 days after onset of 
illness, an eight-fold increase of anti-TOSV IgM was 
demonstrated, accompanied by a five-fold increase for 
anti-TOSV IgG (Table). 
The patient gradually improved under analgesic and 
anti-emetic therapy. On day 15 after onset of illness he 
could be transferred to a rehabilitation centre and fully 
Figure
Multiple skin lesions due to the insect bites on arm of 
sandfly fever patient, Switzerland, October 2011
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recovered 21 days after onset of symptoms. The patient 
suffered no relapse in the following eight months. 
Case 2 and accompanying persons
Case 2, a woman in her early 50s, showed positive IgM 
antibodies against TOSV and SFNV in a serum taken 11 
days after onset of illness, with a 10-fold increase in 
anti-TOSV IgM and a seroconversion for anti-TOSV IgG 
antibodies in a follow-up serum, taken on day 52 after 
onset of illness (Table). 
Serum samples were also taken from the couple’s chil-
dren and the two accompanying travellers on day 52 
after onset of illness of patients 1 and 2. All samples 
were tested by IIFT and IB and turned out negative for 
IgM and IgG antibodies against TOSV, SFNV, SFSV, and 
SFCV.
Leishmania species are known to be transmitted by 
Phlebotomus perniciosus in Malta [5]. Patients were 
informed to remain alert for late appearing symptoms 
of leishmaniasis, which may not manifest until months 
after infection [5]. However, in the following eight 
months, none of the travellers developed clinical signs 
of leishmaniasis. 
Background
Phleboviruses of the Bunyaviridae family, transmitted 
to humans by arthropods, are found in Europe, Africa, 
central Asia, and the Americas. In Mediterranean 
Europe, the phleboviruses Toscana virus (TOSV), sand-
fly fever Naples virus (SFNV), sandfly fever Sicilian 
virus (SFSV), and sandfly fever Cyprus virus (SFCV) are 
transmitted by phlebotomine sandflies. Among these, 
TOSV circulates in countries around the Mediterranean 
Sea (Algeria, Cyprus, France, Greece, Italy, Portugal, 
Spain and Turkey) [1,2]. 
TOSV may cause an acute, nonfatal, influenza-like 
symptomatology or even aseptic meningitis and menin-
goencephalitis [2-4]. SFNV, SFSV and other related 
viruses can cause the so-called ’three-day fever’ or 
’pappataci fever’. Patients present with influenza-like 
symptoms including fever, retro-orbital pain, myalgia 
and malaise and usually recover fully within a week. 
However, infections with these viruses, even when 
mild, have been shown to be highly incapacitating dur-
ing the time the patients are affected [2]. 
Discussion
Viruses in the genus Phlebovirus can cause a variety 
of clinical syndromes ranging from a brief, self-limiting 
febrile illness to encephalitis, meningoencephalitis 
and fatal haemorrhagic fever. Of our cases, the male 
patient suffered from symptoms of a SFV infection that 
incapacitated him for two weeks, while his wife had 
less severe symptoms. The other four travellers accom-
panying the couple were not infected, despite multiple 
insect bites.
The Phlebovirus genus consists of more than 60 distinct 
virus serotypes. While antigenically unrelated to mem-
bers of other genera in the family Bunyaviridae, vari-
ous degrees of cross-reactivity in serological tests can 
occur within the genus, as reported for the SFNV and 
SFSV antigenic complexes [6,7]. Our patients showed 
table 
Serology results for two patients with sandfly fever, Switzerland ex Malta, October 2011
Case 1 Case 2
Days post-onset of illness 10 52 11 52
TOSV IgM IB ++ ++ +/- ++
TOSV IgG IB ++ ++ - ++
TOSV IgM IIFT 400 3,200 100 1,000
TOSV IgG IIFT 2,000 10,000 - 1,000
SFNV IgM IIFT 400 1,000 100 320
SFNV IgG IIFT 1,000 1,000 - 100
SFSV IgM IIFT - - - -
SFSV IgG IIFT - - - -
SFCV IgM IIFT - - - -
SFCV IgG IIFT - - - -
IB: bunyavirus immunoblot, IIFT: indirect immunofluorescence test; SFCV: sandfly fever Cyprus virus; SFNV: sandfly fever Naples virus; SFSV: 
sandfly fever Sicilian virus; TOSV: Toscana virus.
++   strong reactivity, 
+/-  weak reactivity,
-     no reactivity/no immunofluorescence.
Numbers refer to reciprocal titres, according to the dilution scheme of the manufacturer. End-point titres were adjusted to the strength of 
immunofluorescence, e.g. end-point titre 1:3,200, if serum-dilution 1:1,000 showed medium strength of immunofluorescence.
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cross-reactions in the IIFT using SFNV and TOSV anti-
gens, both members of the SFNV antigenic complex. 
Although IIFT using SFSV and SFCV as antigens yielded 
negative results, reactions with other serotypes in the 
genus Phlebovirus cannot be ruled out. 
Viral neutralisation tests (VNT) using early convales-
cent sera remain the serological reference method to 
identify these viruses or to assess the specificity of the 
antibody response [8]. Although generally regarded 
as the gold standard assay for specificity, the VNT is 
relatively labour-intensive and only established in few 
laboratories. SFV-specific commercial assays such as 
IIFT, enzyme-linked immunoassay and IB are much 
more commonly used. For the diagnosis of the cases 
described here, we used IIFT for screening purposes 
and the IB as confirmatory assay [8]. 
Direct viral diagnosis by isolation and RT-PCR from 
blood or cerebrospinal fluid is only possible in the early 
stages of infection, i.e. the first two days after onset of 
symptoms and before seroconversion [2]. Case 1 pre-
sented on day 9 after symptom onset, at a time when 
SFV-specific serology was already positive. Diagnosis 
was therefore attempted by serological investigation, 
using two commercial kits. That the increase in anti-
TOSV IgM and IgG in the convalescent serum of Case 
1 was higher than the increase in antibodies against 
SFNV, was suggestive of an infection with TOSV rather 
than with SFNV. Similarly in Case 2,  anti-TOSV IgM 
increased more than anti-SFNV IgM and was accompa-
nied by higher seroconversion for anti-TOSV IgG than 
for SFNV-IgG. 
Most cases of TOSV infection have been reported in 
residents of or travellers to central Italy and Spain, 
and sporadically in other Mediterranean regions such 
as Portugal, Cyprus, southern France and Greece [9]. 
Asymptomatic infections have also been described [9]. 
Unlike the other SFV serotypes, TOSV shows a peculiar 
neurotropism. It can cause meningitis or meningoen-
cephalitis from which patients generally recover within 
seven to 10 days [9]. TOSV infections occur particularly 
during the summer and correlate with the life cycle 
of the insect vectors Phlebotomus perniciosus and 
P. perfiliewi [9].
TOSV has been isolated from P. perfiliewi and 
P. perniciosus. The latter vector is distributed through-
out the Mediterranean region as two races. SFNV has 
been isolated in Italy from P. perniciosus, in Serbia 
from P. perfiliewi and in Egypt from P. papatasi [10]. 
The typical P. perniciosus race occurs in Italy as well as 
in Tunisia, Morocco and in Malta [10]. However, to the 
best of our knowledge, neither TOSV nor SFNV infec-
tions have been reported from Malta so far. Thus, in 
connection with the beginning of the summer season, 
it is now of particular relevance to consider sandfly-
borne phleboviruses in the differential diagnosis of 
patients returning from Malta and presenting with 
febrile illness.
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